Company:  CANDEL THERAPEUTICS, INC. (CADL)
Form Type:  S-8
Filing Date:  7/29/2021 
CIK:  0001841387 
Address:  117 KENDRICK STREET
SUITE 450
 
City, State, Zip:  NEEDHAM, Massachusetts 02494 
Telephone:  617-916-5445 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$10.35  
Change: 
-0.10 (-0.96%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$296.94M
Trade CADL now with 

© 2021  
Description of Business
We are a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies. Our engineered viruses are designed to induce immunogenic death through direct viral-mediated cytotoxicity in cancer cells, thus releasing tumor neo-antigens and creating a pro-inflammatory microenvironment at the site of injection. Our approach combines an in-depthknowledge of viral immunotherapy with extensive clinical experience across a wide range of indications. Based on the broad range of data that we have generated from our preclinical models and clinical trials using our approach, we have observed what we believe to be systemic immune response against locally injected tumors and their distant metastases. We have established two oncolytic viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs.
Register and access this filing in:     
  FORM S-8
    Candel Therapeutics, Inc. 2015 Stock Plan
    CALCULATION OF REGISTRATION FEE
    Part I
      Item 1. Plan Information.
      Item 2. Registrant Information and Employee Plan Annual ...
    Part II
      Item 3. Incorporation of Documents by Reference.
    Item 4. Description of Securities.
    Item 5. Interests of Named Experts and Counsel.
      Item 6. Indemnification of Directors and Officers.
      Item 7. Exemption from Registration Claimed.
      Item 8. Exhibits.
    EXHIBIT INDEX
      Item 9. Undertakings.
    SIGNATURES
    POWER OF ATTORNEY AND SIGNATURES
  EXHIBIT 5.1
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm